Founded in 2002 in Brisbane, Australia, QIC BioVentures is a venture capital arm of Queensland Investment Corporation. Specializing in biotechnology, the firm focuses on maximizing returns on investments in companies that provide toxic pest products, biopharmaceuticals, therapeutics for diabetes, injectable antibodies, and software solutions. They invest during venture rounds and have a preference for startups that are 6-10 years old. Some of their popular portfolio startups include Gelesis, Columna, and Hatchtech.